HER2

New Breast Cancer Treatment Awaiting FDA ApprovalThe new drug, called Perjeta, is designed to shrink breast cancer tumors before surgery in the 20 percent of women with tumors fueled by the HER2 positive protein.

More From CBS St. Louis

Listen Now
Holiday Guide
Introducing Your New Podcast Network

Listen Live